Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer Clinical Trial
Official title:
Double-Blind Randomised Phase II Trial of Carboplatin and Pemetrexed With or Without AZD1775 in Patients With Previously Untreated Stage IV Non-Squamous Non-Small-Cell Lung Cancer
The aim of this study is to combine AZD1775 with standard front-line chemotherapy in subjects with advanced NSCLC.
This is a randomised, double-blind, placebo-controlled, phase II trial comparing AZD1775 plus carboplatin and pemetrexed with a maintenance phase. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment